Engineers Gate Manager LP Rvl Pharmaceuticals PLC Transaction History

Engineers Gate Manager LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.21 - $1.81 $6,434 - $9,625	-5,318 Reduced 19.56%	21,870 $30,000
Q1 2022 May 16, 2022	SELL	$1.03 - $2.01 $16,090 - $31,400	-15,622 Reduced 36.49%	27,188 $46,000
Q4 2021 Feb 14, 2022	BUY	$0.98 - $3.06 $16,552 - $51,683	16,890 Added 65.16%	42,810 $46,000
Q3 2021 Nov 15, 2021	SELL	$2.79 - $4.19 $24,937 - $37,450	-8,938 Reduced 25.64%	25,920 $76,000
Q2 2021 Aug 16, 2021	SELL	$2.8 - $3.78 $71,568 - $96,616	-25,560 Reduced 42.31%	34,858 $105,000
Q1 2021 May 17, 2021	SELL	$3.26 - $4.84 $110,709 - $164,366	-33,960 Reduced 35.98%	60,418 $197,000
Q4 2020 Feb 16, 2021	BUY	$4.12 - $6.29 $89,358 - $136,423	21,689 Added 29.84%	94,378 $389,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $8.77 $65,407 - $119,008	13,570 Added 22.95%	72,689 $393,000
Q2 2020 Aug 17, 2020	BUY	$2.83 - $6.99 $50,761 - $125,379	17,937 Added 43.56%	59,119 $398,000
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $27,599 - $60,753	8,679 Added 26.7%	41,182 $131,000
Q4 2019 Feb 14, 2020	BUY	$3.46 - $7.7 $112,460 - $250,273	32,503 New	32,503 $227,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.